56715-13-0
56715-13-0
Chemical Structure
(R)-(+)-Atenolol
- CAS. Nr.: 56715-13-0
- Formula:C14H22N2O3
- Molecular Weight:266.34
IUPAC Name: (R)-2-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
InChIKey: METKIMKYRPQLGS-GFCCVEGCSA-N
SMILES: O=C(N)CC1=CC=C(OC[C@H](O)CNC(C)C)C=C1
Biological Activity: (R)-(+)-Atenolol is the less active enantiomer of the (R,S)-atenolol. (R,S)-atenolol is a β-adrenergic receptor antagonist[1][2].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(R)-(+)-Atenolol | 98.57% | (R)-(+)-Atenolol is the less active enantiomer of the (R,S)-atenolol. (R,S)-atenolol is a β-adrenergic receptor antagonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Batra S, et al. Bioassay, determination and separation of enantiomers of atenolol by direct and indirect approaches using liquid chromatography: A review. Biomed Chromatogr. 2018 Jan;32(1). [Content Brief]
- [2]. Stoschitzky K, et al. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies. Chirality. 1993;5(1):15-9. [Content Brief]
